Regulation of Endothleial Cell Apoptosis by HO-1 and CO
Regulation of Endothleial Cell Apoptosis by HO-1 and CO
批准号:
6745108
负责人:
FRITZ H BACH
金额:
$29.75万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION(Applicant's abstract): Endothelial cell (EC) apoptosis, such as it
occurs during acute or chronic inflammation, is a highly pro-inflammatory event
that can lead to irreversible tissue injury, organ failure and disease.
Understanding how EC protect themselves from undergoing apoptosis in situations
of stress may be critical in the development of therapeutic strategies aimed
suppress the deleterious effects associated with acute and/or chronic
inflammation. One of the physiological mechanisms by which EC protect
themselves from undergoing apoptosis relies on the expression of a series of
cytoprotective genes. We will study one of such protective genes in this
proposal, the stress responsive gene heme oxygenase-l (HO-1). Under
inflammatory conditions HO-1 becomes the rate limiting enzyme in the catabolism
of heme to yield equimolar amounts of bilirubin, free iron and the gaseous
molecule carbon monoxide (CU). Our preliminary studies suggest that the
cytoprotective effects of HO-1 are largely mediated through the generation of
CO. Expression of HO-1 in vivo can suppress acute inflammatory reactions such
as those associated with the rejection of a transplanted organ. Presumably,
this cytoprotective effect relies on the ability of HO-1 to prevent EC
apoptosis. This is supported by the observation that expression of HO-1 in
vitro can prevent EC from undergoing apoptosis. In both cases the
cytoprotective effect of HO-1 is mediated through the generation of CO. The
anti-apoptotic effect of HO-1/CO is dependent on the activation of the p38
mitogen activated protein kinase (MAPK) signal transduction pathway and the
activation of the transcription factor NF-KB. Presumably this events lead to
the up-regulation of expression of NF-KB dependent protective genes that
contribute to suppress EC apoptosis. This proposal aims to analyze the
mechanism(s) by which HO-1 and its derivative CO protect EC from undergoing
apoptosis. We propose to identify mechanism by which HO-1 and CO activate p38
MAPK as well as the transcription factor NF-KB and to determine how these
events contribute to prevent EC apoptosis. We believe that the results gained
in these application, which reveal for the first time the potent anti-apoptotic
effect of CO, will provide valuable information that will contribute to the
development of new approaches to overcome pathologic conditions associated with
acute and/or chronic inflammation, including septic shock, atherosclerosis
and/or the rejection of immediately vascularized transplanted organs.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7538400
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7166066
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7327813
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase-1: protection against chronic rejection
-
批准号:7035144
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2006
-
负责人:FRITZ H BACH
-
依托单位:
Heme Oxygenase 2005 -- the 4th International Conference
-
批准号:7001754
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:FRITZ H BACH
-
依托单位:
Regulation of Endothleial Cell Apoptosis by HO-1 and CO
-
批准号:6638740
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2001
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:6184287
-
项目类别:
-
资助金额:$32.71万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:6389716
-
项目类别:
-
资助金额:$33.42万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:2637613
-
项目类别:
-
资助金额:$31.37万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS
-
批准号:6056438
-
项目类别:
-
资助金额:$32.03万
-
财政年份:1998
-
负责人:FRITZ H BACH
-
依托单位:
MOLECULAR STUDIES OF NK CELLS AND NK/LAK FUNCTION
-
批准号:3128427
-
项目类别:
-
资助金额:$17.83万
-
财政年份:1992
-
负责人:FRITZ H BACH
-
依托单位:
MOLECULAR STUDIES OF NK CELLS AND NK/LAK FUNCTION
-
批准号:2060837
-
项目类别:
-
资助金额:$31.57万
-
财政年份:1992
-
负责人:FRITZ H BACH
-
依托单位:
DISCORDANT XENOGRAFTING
-
批准号:3365969
-
项目类别:
-
资助金额:$9.73万
-
财政年份:1991
-
负责人:FRITZ H BACH
-
依托单位:
DISCORDANT XENOGRAFTING
-
批准号:3365970
-
项目类别:
-
资助金额:$11.8万
-
财政年份:1991
-
负责人:FRITZ H BACH
-
依托单位:
DISCORDANT XENOGRAFTING
-
批准号:2223218
-
项目类别:
-
资助金额:$13.25万
-
财政年份:1991
-
负责人:FRITZ H BACH
-
依托单位:
ESTABLISHMENT OF UPGRADED FLOW CYTOMETRY SYSTEM CORE
-
批准号:3520383
-
项目类别:
-
资助金额:$31.5万
-
财政年份:1988
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134132
-
项目类别:
-
资助金额:$28.81万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134131
-
项目类别:
-
资助金额:$27.47万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134129
-
项目类别:
-
资助金额:$22.84万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
STUDIES OF HLA CLASS II GENES
-
批准号:3134130
-
项目类别:
-
资助金额:$26.72万
-
财政年份:1985
-
负责人:FRITZ H BACH
-
依托单位:
海外基金